Premium
Stem Cell Science: Current Ethical and Policy Issues
Author(s) -
Mauron A,
Jaconi M E
Publication year - 2007
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/sj.clpt.6100295
Subject(s) - suspect , administration (probate law) , embryonic stem cell , political science , clinical pharmacology , engineering ethics , stem cell , medicine , pharmacology , law , biology , engineering , microbiology and biotechnology , biochemistry , gene
There is increasing support for embryonic stem (ES) cell research on both sides of the Atlantic. In the United States, the outcome is more funding from non‐federal sources, despite the current administration's opposing views. In Europe, a similar pragmatic turn is in the making, but the future is still uncertain. Acceptance of ES cells is mitigated by the uncritical belief that their use is ethically more suspect than is the case for adult cells. Clinical Pharmacology & Therapeutics (2007) 82 , 330–333; doi: 10.1038/sj.clpt.6100295 ; published online 18 July 2007